Clinical Trials Directory

Trials / Unknown

UnknownNCT04047667

Cone Beam CT Guided Transbronchial Cryobiopsy

The Safety and Diagnostic Efficacy of Cone Beam CT Guided Transbronchial Cryobiopsy for ILD Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Interstitial lung diseases (ILD) are common in clinical practices and need multidisciplinary assessment of clinical presentations, radiological and histological features. Transbronchial cryobiopsy (TBCB) is one of the most important invasive procedures for ILD when a confident diagnosis cannot be made by clinical and radiological assessment. TBCB could lead to higher incidence of risks. The pneumothorax and severe bleeding seemed to be more common in patients with TBCB. Cone-beam computed tomography (CBCT) could provide 3-dimensinal (3D) CT images which were close to the image qualities of conventional CT. The probe-to-pleura relationship could be accurately established by the 3D CT scan and the cryobiopsy safety profile might be improved under the guidance of CBCT. In this study, we conducted a prospective study to observe the safety and diagnostic efficacy of CBCT guided TBCB for the DPLD patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREcone beam CT guided transbronchial cryobiopsyCBCT images are acquried and reviewed in axial, coronal and sagittal planes to most accurately assess the cryoprobe position within the lung parenchyma and relative to other thoracic structures. The minimum probe-to-pleura distance will be measured. If the position of cryoprobe is proper, TBCB will be perfomed.

Timeline

Start date
2018-09-01
Primary completion
2019-10-01
Completion
2019-12-01
First posted
2019-08-07
Last updated
2019-08-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04047667. Inclusion in this directory is not an endorsement.